Prognostic significance of p53 overexpression in gastric and colorectal carcinoma

British Journal of Cancer

Volumn 66, Issue 3, 1992, Pages 558-562

  Starzynska, T ^a   Bromley, M ^b   Ghosh, A ^b   Stern, P L ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; POLYCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; COLON ADENOMA; COLORECTAL CARCINOMA; EPITHELIUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; TISSUE FIXATION;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; FROZEN SECTIONS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROGNOSIS; PROTEIN P53; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0026786636     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1992.314     Document Type: Article

References (27)

1. ARAI, N., NOMURA, D., YOKOTA, K. and 4 others (1986). Immunologically distinct p53 molecules generated by alternate splicing. Mol. Cell Biol., 6, 3232
2. BAKER, S.J., FEARON, E.R., NIGRO, J.H. and 9 others (1989). Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science, 244, 217
3. BARTER, J., BARTKOVA, J., VOJTESEK, B. and 4 others (1990a). Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int. J. Cancer, 46, 839
4. BARTER, J., IGGO, R., GANNON, J. and LANE, D.P. (1990b). Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene, 5, 893
5. BARTKOVA, J., BARTER, J., LUKAS, J. and 6 others (1991). p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int. J. Cancer, 49, 196
6. CAMPO, E., DE LA CALLE-MARTIN, O., MIQUEL, R. and 6 others (1991). Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res., 51, 4436
7. CATTORETTI, G., RILKE, F., ANDREOLA, S., D’AMATO, L. and DELIA, D. (1988). p53 expression in breast cancer. Int. J. Cancer, 41, 178
8. CHEN, P.-L., CHEN, Y., BOOKSTEIN, R. and LEE, W.-H. (1990). Genetic mechanisms of tumor suppression by the human p53 gene. Science, 250, 1576
9. CRAWFORD, L.V., PIM, D.C. and LAMB, P. (1984). The cellular protein p53 in human tumours. Mol. Biol. Med., 2, 261
10. DAVIDOFF, A.M., KERNS, B.-J.M., IGLEHART, J.D. and MARKS, J.R. (1991a). Maintenance of p53 alterations throughout breast cancer progression. Cancer Res., 51, 2605
11. DAVIDOFF, A.M., HERNDON, J.E., KERNS, B.-J.M., PENCE, J.P., IGLEHART, J.D. and MARKS, J.R. (1991b). Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery, 110, 259
12. DILLER, L., KASSEL, J., NELSON, C.E. and 8 others (1990). p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell Biol., 10, 5772
13. FIELDING, J.W.L. and PRIESTMAN, T.J. (1986). Gastrointestinal oncology. In: Large Bowel Carcinomas, Leveson, S.H. and Vowolen, P. (eds) pp. 210-224. Castle House Publications Ltd
14. FINLAY, C.A., HINDS, P.W., TAN, T.-H., ELIYAHU, D., OREN, M. and LEVINE, A.J. (1988). Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half life. Mol. Cell Biol., 8, 531
15. FINLAY, C.A., HINDS, P.W. and LEVINE, A.J. (1989). The p53 protooncogene can act as a suppressor of transformation. Cell, 57, 1083
16. GANNON, J.V., GREAVES, R., IGGO, R. and LANE, D.P. (1990). Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J., 9, 1595
17. IGGO, R., GATTER, K., BARTER, J., LANE, D. and HARRIS, A.L. (1990). Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335, 675
18. ISAACS, W.B., CARTER, B.S. and EWING, Ch.M. (1991). Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res., 51, 4716
19. OREN, M., MALTZMAN, W. and LEVINE, A.J. (1981). Post translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell Biol., 1, 101
20. MARKS, J.R., DAVIDOFF, A.M., KERNS, B.J. and 7 others (1991). Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res., 51, 2979
21. NIGRO, J.M., BAKER, S.J., PREISINGER, A.C. and 13 others (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705
22. PREECE, P.E., CUSCHIERI, A. and WELLWOOD, J.M. (1986). Cancer of the stomach. Grune and Stratton Ltd
23. REMVIKOS, Y., LAURENT-PUIG, P., SALMON, R.J., FRELAT, G., DUTRILLAUX, B. and THOMAS, G. (1990). Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int. J. Cancer, 45, 450
24. RODRIGUES, N.R. ROWAN, A., SMITH, M.E.F. and 4 others (1990). p53 mutations in colorectal cancer. Proc. Natl Acad. Sci. USA, 87, 7555
25. SCOTT, N., SAGAR, P., STEWART, J., BLAIR, G.E., DIXON, M.F. and QUIRKE, P, (1991). p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br. J. Cancer, 63, 317
26. TAKAHASHI, T., NAU, M.M., CHIBA, I. and 7 others (1989). p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491
27. TAMURA, G., KIHANA, T., NOMURA, K., TERADA, M., SUGIMURA, T. and HIROHASHI, S. (1991). Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res., 51, 3056